Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 July 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 206 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 74 results:
Author Title Type [ Year(Asc)]
Filters: Author is Garcia Rodriguez, L. A.  [Clear All Filters]
2020
H. J. L. Heerspink, Karasik, A., Thuresson, M., Melzer-Cohen, C., Chodick, G., Khunti, K., Wilding, J. P. H., Rodriguez, L. A. Garcia, Cea-Soriano, L., Kohsaka, S., Nicolucci, A., Lucisano, G., Lin, F. J., Wang, C. Y., Wittbrodt, E., Fenici, P., and Kosiborod, M., “Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study”, Lancet Diabetes Endocrinol, vol. 8, pp. 27-35, 2020.
2019
L. A. Garcia Rodriguez, Martin-Perez, M., Vora, P., Roberts, L., Balabanova, Y., Brobert, G., Fatoba, S., Suzart-Woischnik, K., Schaefer, B., and Ruigomez, A., “Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK”, BMJ Open, vol. 9, p. e031341, 2019.
2016
R. Brauer, Ruigomez, A., Downey, G., Bate, A., Rodriguez, L. A. Garcia, Huerta, C., Gil, M., de Abajo, F., Requena, G., Alvarez, Y., Slattery, J., de Groot, M., Souverein, P., Hesse, U., Rottenkolber, M., Schmiedl, S., de Vries, F., Tepie, M. F., Schlienger, R., Smeeth, L., Douglas, I., Reynolds, R., and Klungel, O., “Prevalence of antibiotic use: a comparison across various European health care data sources”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 11-20, 2016.
2013
L. A. Garcia Rodriguez, Johansson, S., and L. Soriano, C., “Use of clopidogrel and proton pump inhibitors after a serious acute coronary event: risk of coronary events and peptic ulcer bleeding”, Thromb Haemost, vol. 110, pp. 1014-24, 2013.
2011
E. Martin-Merino, Johansson, S., Morris, T., and Rodriguez, L. A. Garcia, “Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care”, Drug Saf, vol. 34, pp. 1061-77, 2011.
2010
S. Johansson, Wallander, M. A., de Abajo, F. J., and Rodriguez, L. A. Garcia, “Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios”, Drug Saf, vol. 33, pp. 223-32, 2010.
2009
L. A. Garcia Rodriguez, Wallander, M. A., Tolosa, L. B., and Johansson, S., “Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors”, Copd, vol. 6, pp. 369-79, 2009.
2008
L. A. Garcia Rodriguez, Ruigomez, A., Martin-Merino, E., Johansson, S., and Wallander, M. A., “Relationship between gastroesophageal reflux disease and COPD in UK primary care”, Chest, vol. 134, pp. 1223-1230, 2008.
2007
M. A. Wallander, Johansson, S., Ruigomez, A., Rodriguez, L. A. Garcia, and Jones, R., “Morbidity associated with sleep disorders in primary care: a longitudinal cohort study”, Prim Care Companion J Clin Psychiatry, vol. 9, pp. 338-45, 2007.
C. Huerta, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom”, Arch Intern Med, vol. 167, pp. 935-43, 2007.
A. Ruigomez, Rodriguez, L. A. Garcia, Johansson, S., Wallander, M. A., and Edvardsson, N., “Risk of cerebrovascular accident after a first diagnosis of atrial fibrillation”, Clin Cardiol, vol. 30, pp. 624-8, 2007.
M. A. Wallander, Johansson, S., Ruigomez, A., and Rodriguez, L. A. Garcia, “Unspecified abdominal pain in primary care: the role of gastrointestinal morbidity”, Int J Clin Pract, vol. 61, pp. 1663-70, 2007.
2006
L. A. Garcia Rodriguez, Ruigomez, A., and Panes, J., “Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease”, Gastroenterology, vol. 130, pp. 1588-94, 2006.
S. Hernandez-Diaz and Rodriguez, L. A. Garcia, “Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications”, BMC Med, vol. 4, p. 22, 2006.
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., and Dent, J., “Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care”, Curr Med Res Opin, vol. 22, pp. 1661-8, 2006.
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., and Eklund, S., “Esophageal stricture: incidence, treatment patterns, and recurrence rate”, Am J Gastroenterol, vol. 101, pp. 2685-92, 2006.
A. Arana, Varas, C., Gonzalez-Perez, A., Gutierrez, L., Bjerrum, L., and Rodriguez, L. A. Garcia, “Hormone therapy and cerebrovascular events: a population-based nested case-control study”, Menopause, vol. 13, pp. 730-6, 2006.
C. Huerta, Varas-Lorenzo, C., Castellsague, J., and Rodriguez, L. A. Garcia, “Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population”, Heart, vol. 92, pp. 1610-5, 2006.
M. A. Hernan, Logroscino, G., and Rodriguez, L. A. Garcia, “Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease”, Neurology, vol. 66, pp. 1097-9, 2006.
2005
A. Gonzalez-Perez and Rodriguez, L. A. Garcia, “Breast cancer risk among users of antidepressant medications”, Epidemiology, vol. 16, pp. 101-5, 2005.
C. Huerta, Castellsague, J., Varas-Lorenzo, C., and Rodriguez, L. A. Garcia, “Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population”, Am J Kidney Dis, vol. 45, pp. 531-9, 2005.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK”, BMC Cardiovasc Disord, vol. 5, p. 20, 2005.
A. Gonzalez-Perez and Rodriguez, L. A. Garcia, “Prostate cancer risk among men with diabetes mellitus (Spain)”, Cancer Causes Control, vol. 16, pp. 1055-8, 2005.
C. Huerta, Lanes, S. F., and Rodriguez, L. A. Garcia, “Respiratory medications and the risk of cardiac arrhythmias”, Epidemiology, vol. 16, pp. 360-6, 2005.
L. A. Garcia Rodriguez and Gonzalez-Perez, A., “Use of antibiotics and risk of breast cancer”, Am J Epidemiol, vol. 161, pp. 616-9, 2005.
2004
F. J. de Abajo, Montero, D., Madurga, M., and Rodriguez, L. A. Garcia, “Acute and clinically relevant drug-induced liver injury: a population based case-control study”, Br J Clin Pharmacol, vol. 58, pp. 71-80, 2004.
A. Gonzalez-Perez, Ronquist, G., and Rodriguez, L. A. Garcia, “Breast cancer incidence and use of antihypertensive medication in women”, Pharmacoepidemiol Drug Saf, vol. 13, pp. 581-5, 2004.
L. A. Garcia Rodriguez and Gonzalez-Perez, A., “Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer”, Cancer Epidemiol Biomarkers Prev, vol. 13, pp. 649-53, 2004.
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., Graffner, H., and Dent, J., “Natural history of gastro-oesophageal reflux disease diagnosed in general practice”, Aliment Pharmacol Ther, vol. 20, pp. 751-60, 2004.
L. A. Garcia Rodriguez and Gonzalez-Perez, A., “Risk of breast cancer among users of aspirin and other anti-inflammatory drugs”, Br J Cancer, vol. 91, pp. 525-9, 2004.
2003
A. Ruigomez, Rodriguez, L. A. Garcia, Johansson, S., and Wallander, M. A., “Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome?”, Maturitas, vol. 44, pp. 133-40, 2003.
L. A. Garcia Rodriguez and Hernandez-Diaz, S., “Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure”, Epidemiology, vol. 14, pp. 240-6, 2003.
C. Huerta, Rodriguez, L. A. Garcia, Wallander, M. A., and Johansson, S., “Users of oral steroids are at a reduced risk of developing irritable bowel syndrome”, Pharmacoepidemiol Drug Saf, vol. 12, pp. 583-8, 2003.
S. S. Jick, Kaye, J. A., Vasilakis-Scaramozza, C., Rodriguez, L. A. Garcia, Ruigomez, A., Meier, C. R., Schlienger, R. G., Black, C., and Jick, H., “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
2002
S. F. Lanes, Rodriguez, L. A. Garcia, and Huerta, C., “Respiratory medications and risk of asthma death”, Thorax, vol. 57, pp. 683-6, 2002.
C. Huerta, Zhao, S. Z., and Rodriguez, L. A. Garcia, “Risk of acute liver injury in patients with diabetes”, Pharmacotherapy, vol. 22, pp. 1091-6, 2002.
C. Huerta and Rodriguez, L. A. Garcia, “Risk of clinical blood dyscrasia in a cohort of antibiotic users”, Pharmacotherapy, vol. 22, pp. 630-6, 2002.
C. Huerta, Rodriguez, L. A. Garcia, Wallander, M. A., and Johansson, S., “Risk of irritable bowel syndrome among asthma patients”, Pharmacoepidemiol Drug Saf, vol. 11, pp. 31-5, 2002.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation”, BMC Cardiovasc Disord, vol. 2, p. 5, 2002.
2001
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Gender and drug treatment as determinants of mortality in a cohort of heart failure patients”, Eur J Epidemiol, vol. 17, pp. 329-35, 2001.
S. Johansson, Wallander, M. A., Ruigomez, A., and Rodriguez, L. A. Garcia, “Incidence of newly diagnosed heart failure in UK general practice”, Eur J Heart Fail, vol. 3, pp. 225-31, 2001.
L. A. Garcia Rodriguez and Hernandez-Diaz, S., “Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs”, Epidemiology, vol. 12, pp. 570-6, 2001.
C. Huerta, Rodriguez, L. A. Garcia, Moller, C. S., and Arellano, F. M., “The risk of obstructive airways disease in a glaucoma population”, Pharmacoepidemiol Drug Saf, vol. 10, pp. 157-63, 2001.
F. J. de Abajo and Rodriguez, L. A. Garcia, “Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations”, BMC Clin Pharmacol, vol. 1, p. 1, 2001.
L. A. Garcia Rodriguez and Hernandez-Diaz, S., “The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents”, Arthritis Res, vol. 3, pp. 98-101, 2001.
2000
A. Ruigomez, Rodriguez, L. A. Garcia, Dev, V. J., Arellano, F., and Raniwala, J., “Are schizophrenia or antipsychotic drugs a risk factor for cataracts?”, Epidemiology, vol. 11, pp. 620-3, 2000.
L. A. Garcia Rodriguez, Ruigomez, A., Wallander, M. A., Johansson, S., and Olbe, L., “Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome”, Scand J Gastroenterol, vol. 35, pp. 306-11, 2000.
L. A. Garcia Rodriguez, Varas, C., and Patrono, C., “Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women”, Epidemiology, vol. 11, pp. 382-7, 2000.
A. Ruigomez, Rodriguez, L. A. Garcia, Hasselgren, G., Johansson, S., and Wallander, M. A., “Overall mortality among patients surviving an episode of peptic ulcer bleeding”, J Epidemiol Community Health, vol. 54, pp. 130-3, 2000.
L. A. Garcia Rodriguez and Huerta-Alvarez, C., “Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study”, Epidemiology, vol. 11, pp. 376-81, 2000.
[Page last reviewed 6 July 2020]